Studies have also confirmed that inhibition of cytokine pathways associated with cachexia formation has been shown to enhance the anti-cancer immune response [39, 40], and the combined blocking of specific cachexia-promoting mediators and the PD-1/PD-L1 axis has been shown to have a synergistic effect [41, 42]. The gene discussed is CD274; the disease is Cachexia.